Fingerprint
Dive into the research topics of 'Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Michael Auerbach, Peter T. Silberstein, R. Timothy Webb, Svetlana Averyanova, Tudor Eliade Ciuleanu, James Shao, Kenneth Bridges
Research output: Contribution to journal › Article › peer-review
78
Scopus
citations